Literature DB >> 32639582

Associations between clinical features and therapy with macrophage subpopulations and T cells in inflammatory lesions in the aorta from patients with Takayasu arteritis.

J P Dos Santos1, R Artigiani Neto2, C L P Mangueira3, R Z Filippi4, P S Gutierrez5, J Westra6, E Brouwer6, A W S de Souza1.   

Abstract

Takayasu arteritis (TAK) is a large-vessel granulomatous vasculitis; the inflammatory infiltration in arteries comprises macrophages, multi-nucleated giant cells, CD4+ and CD8+ T cells, γδ T cells, natural killer (NK) cells and neutrophils. However, it is unknown which subtype of macrophages predominates. This study aims to evaluate macrophages subpopulations in the aorta in TAK. Immunohistochemistry was performed in the aorta from TAK patients (n = 22), patients with atherosclerotic disease (n = 9) and heart transplant donors (n = 8) using the markers CD68, CD86, CD206, CD3, CD20 and CD56. Active disease was observed in 54·5% of patients and active histological lesions were found in 40·9%. TAK patients presented atherosclerotic lesions in 27·3% of cases. The frequency of macrophages, M1 macrophages, T, B and NK cells was higher in the aorta from TAK and atherosclerotic patients compared to heart transplant donors. In TAK, macrophages and T cells were the most abundant cells in the aorta, and the expression of CD206 was higher than CD86 (P = 0·0007). No associations were found between the expression of cell markers and active disease or with atherosclerotic lesions. In TAK patients, histological disease activity led to higher T cell counts than chronic fibrotic lesions (P = 0.030), whereas prednisone use was associated with lower T cell counts (P = 0·035). In conclusion, M1 macrophages were more frequent in TAK and atherosclerotic patients compared to heart transplant donors, while M2 macrophages dominated M1 macrophages in TAK. T cells were associated with histological disease activity and with prednisone use in TAK.
© 2020 British Society for Immunology.

Entities:  

Keywords:  B cells; NK cells; T cells; Takayasu arteritis; innate immunity; macrophages

Mesh:

Substances:

Year:  2020        PMID: 32639582      PMCID: PMC7670142          DOI: 10.1111/cei.13489

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  45 in total

Review 1.  Macrophage plasticity and polarization: in vivo veritas.

Authors:  Antonio Sica; Alberto Mantovani
Journal:  J Clin Invest       Date:  2012-03-01       Impact factor: 14.808

Review 2.  Diagnostic criteria for Takayasu arteritis.

Authors:  B K Sharma; S Jain; S Suri; F Numano
Journal:  Int J Cardiol       Date:  1996-08       Impact factor: 4.164

Review 3.  Macrophage plasticity and polarization in tissue repair and remodelling.

Authors:  Alberto Mantovani; Subhra K Biswas; Maria Rosaria Galdiero; Antonio Sica; Massimo Locati
Journal:  J Pathol       Date:  2012-11-29       Impact factor: 7.996

Review 4.  Takayasu arteritis: insights into immunopathology.

Authors:  Y Seko
Journal:  Jpn Heart J       Date:  2000-01

5.  Silent arterial inflammation during the apparent remission state of Takayasu's arteritis. What do cytokines tell us?

Authors:  Bruna Savioli; Bruno Ramos Salu; Marlon Vilela de Brito; Maria Luiza Vilela Oliva; Alexandre W S de Souza
Journal:  Clin Exp Rheumatol       Date:  2018-03-19       Impact factor: 4.473

6.  Disturbed B cell homeostasis in newly diagnosed giant cell arteritis and polymyalgia rheumatica.

Authors:  Kornelis S M van der Geest; Wayel H Abdulahad; Paulina Chalan; Abraham Rutgers; Gerda Horst; Minke G Huitema; Mirjam P Roffel; Caroline Roozendaal; Philip M Kluin; Nicolaas A Bos; Annemieke M H Boots; Elisabeth Brouwer
Journal:  Arthritis Rheumatol       Date:  2014-07       Impact factor: 10.995

7.  Takayasu arteritis.

Authors:  G S Kerr; C W Hallahan; J Giordano; R Y Leavitt; A S Fauci; M Rottem; G S Hoffman
Journal:  Ann Intern Med       Date:  1994-06-01       Impact factor: 25.391

8.  Perforin-secreting killer cell infiltration and expression of a 65-kD heat-shock protein in aortic tissue of patients with Takayasu's arteritis.

Authors:  Y Seko; S Minota; A Kawasaki; Y Shinkai; K Maeda; H Yagita; K Okumura; O Sato; A Takagi; Y Tada
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

9.  Pathology of Takayasu arteritis: A brief review.

Authors:  Pradeep Vaideeswar; Jaya R Deshpande
Journal:  Ann Pediatr Cardiol       Date:  2013-01

10.  Massive B-Cell Infiltration and Organization Into Artery Tertiary Lymphoid Organs in the Aorta of Large Vessel Giant Cell Arteritis.

Authors:  Jacoba C Graver; Annemieke M H Boots; Erlin A Haacke; Arjan Diepstra; Elisabeth Brouwer; Maria Sandovici
Journal:  Front Immunol       Date:  2019-01-29       Impact factor: 7.561

View more
  5 in total

1.  The role of CD8+ Granzyme B+ T cells in the pathogenesis of Takayasu's arteritis.

Authors:  Taotao Li; Na Gao; Wei Cui; Limin Zhao; Juan Du; Xuemei Shi; Junming Zhu; Zhiyu Qiao; Shichao Guo; Lili Pan
Journal:  Clin Rheumatol       Date:  2021-09-07       Impact factor: 2.980

2.  Pathogenesis of liver injury in Takayasu arteritis: advanced understanding leads to new horizons.

Authors:  Kai Kang; Yue Sun; Yi Ling Li; Bing Chang
Journal:  J Int Med Res       Date:  2020-12       Impact factor: 1.671

3.  A comprehensive profile of chemokines in the peripheral blood and vascular tissue of patients with Takayasu arteritis.

Authors:  Xiufang Kong; Sifan Wu; Xiaojuan Dai; Wensu Yu; Jinghua Wang; Ying Sun; Zongfei Ji; Lingying Ma; Xiaomin Dai; Huiyong Chen; Lili Ma; Lindi Jiang
Journal:  Arthritis Res Ther       Date:  2022-02-16       Impact factor: 5.156

Review 4.  Pathogenic role of monocytes/macrophages in large vessel vasculitis.

Authors:  Ryu Watanabe; Motomu Hashimoto
Journal:  Front Immunol       Date:  2022-07-29       Impact factor: 8.786

5.  Potential Role of Macrophage Phenotypes and CCL2 in the Pathogenesis of Takayasu Arteritis.

Authors:  Xiufang Kong; Ming Xu; Xiaomeng Cui; Lingying Ma; Huiyong Cheng; Jun Hou; Xiaoning Sun; Lili Ma; Lindi Jiang
Journal:  Front Immunol       Date:  2021-05-17       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.